Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Patent
1996-04-19
2000-12-05
Wortman, Donna C.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
4353201, 530826, 530350, C12Q 170, C12N 1500
Patent
active
061564958
ABSTRACT:
Recombinantly produced hepatitis GB Virus (HGBV) amino acid sequences useful for a variety of diagnostic and therapeutic applications, kits for using the HGBV amino acid sequences and antibodies which specifically bind to HGBV. Also provided are methods for producing antibodies, polyclonal or monoclonal, from the HGBV recombinantly produced amino acid sequences.
REFERENCES:
patent: 4743535 (1988-05-01), Carrico
patent: 4876187 (1989-10-01), Duck et al.
patent: 5275947 (1994-01-01), Arima et al.
patent: 5399346 (1995-03-01), Anderson et al.
patent: 5527669 (1996-06-01), Resnick et al.
patent: 5576302 (1996-11-01), Cook et al.
patent: 5766840 (1998-06-01), Kim et al.
T. Peters et al., Frequency of Hepatitis C in Acute Post-Transfusion Hepatitis After Open-Heart Surgery: A Prospective Study in 1,476 Patients, Journal of Medical Virology vol. 39: 139-145 (1993).
R. Purcell, The Discovery of the Hepatitis Viruses, Gastroenterology vol. 104, No. 4: 955-963 (1993).
G. Dawson et al., Solid-phase enzyme-linked immunosobent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides, Journal of Virological Methods vol. 38: 175-186 (1992).
P. Yarbough et al., Hepatitis E Virus: Identification of Type-Common Epitopes, Journal of Virology vol. 65 No. 11: p. 5790-5797 (1991).
H. Alter et al., Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis, The New England Journal of Medicine vol. 321 No. 22: p. 1494-1500 (1989).
M. Alter et al., Risk Factors for Acute Non-A, Non-B Hepatitis in the United States and Association With Hepatitis C Virus Infection, JAMA vol. 264 No. 17: p. 2231-2235 (1990).
J. Dienstag, Hepatitis Non-A, Non-B: C at Last, Gastroenterology vol. 99 No. 4: p. 1177-1180 (1990).
G. Reyes et al., Isolation of a cDNA from the Virus Responsible for Enterically Transmitted Non-A, Non-B Hepatitis, Science vol. 247 : p. 1335-1339 (1990).
G. Kuo et al., An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis, Science vol. 244 : p. 362-364 (1989).
A. Weineret al., Detection of hepatitis C viral sequences in non-A, non-B hepatitis, The Lancet vol. 335: p. 1-3 (1990).
G. Schlauder et al., Viraemia in Egyptian children with hepatitis E virus infection, The Lancet vol. 341: p. 378 (1993).
N. Lisitsyn et al., Cloning the Differences Between Two Complex Genomes, Science vol. 259: p. 946-951 (1993).
V. Thiers et al., Post-transfusional anti-HCV-negative non-A non-B hepatitis (II) serological and polymerase chain reaction analysis for hepatitis C and hepatitis B viruses, Journal of Hepatology vol. 18: p. 34-39 (1993).
Hepatitis C virus upstanding, The Lancet vol. 335: p. 1431-1432 (1990).
W. Parks et al., Attempted Isolation of Hepatitis Viruses in Marmosets, The Journal of Infectious Diseases vol. 120 No. 5: 539-547 (1969).
A. Holmes et al., Specific Neutralization of Human Hepatitis Type A in Marmoset Monkeys, Nature vol. 243: p. 419-420 (1973).
P. Provost et al., Physical, Chemical and Morphologic Dimensions of Human Hepatitis A Virus Strain CR326 (38578), Proceeding of the Society for Experimental Biology and Medicine vol. 148: p. 532-539 (1975).
Q. Choo et al., Isolation of a cDNA Clone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome, Science vol. 244: p. 359-361 (1989).
J. Almeida et al., Morphology of the GB hepatitis agent, Nature vol. 261: p. 608-609 (1976).
F. Deinhardt et al., Studies on the Transmission of Human Viral Hepatitis to Marmoset Monkeys, Journal of Experimental Medicine vol. 125: p. 673-688, Plate 81-86 (1966).
J. Dienstag, Non-A, Non-B Hepatitis. II. Experimental Transmission, Putative Virus Agents and Markers, and Prevention, Gastroenterology vol. 85 No. 3: p. 743-768 (1983).
F. Hollinger et al., Transfusion-Transmitted Viruses Study: Experimental Evidence for Two Non-A, Non-B Hepatitis Agents, Journal of Infectious Diseases vol. 142 No. 3: p. 400-407 ( 1980).
D. Bradley, Transmission, Etiology, and Pathogenesis of Viral Hepatitis Non-A, Non-B in Non-Human Primates, Advances in Hepatitis Research: p. 268-280 (1984).
F. Deinhardt et al., Hepatitis in marmosets, The American Journal of the Medical Sciences vol. 270: p. 73-80 (1975).
S. Kalter, Comparison of Infectivity of Human Non-A/Non-B Hepatitis and the GB Hepatitis Agent in Marmosets, Viral and Immunological Diseases in Nonhuman Primates;: p. 221-224 (1983).
E. Tabor et al., Transmission of Human Non-A, Non-B Hepatitis to Chimpanzees Following Failure to Transmit GB Agent Hepatitis, Journal of Medical Virology: p. 103-108 (1980).
D. Bradley et al., Posttransfusion Non-A, Non-B Hepatitis: Physicochemical Properties of Two Distinct Agents, The Journal of Infectious Diseases vol. 148 No. 2: p. 254-265 (1983).
J. Dienstag, Virus-like particles and GB agent hepatitis, Nature vol. 264: p. 260-261 (1976).
P. Karayiannis et al., Studies of GB Hepatitis Agent in Tamarins, Hepatology vol. 9 No. 2: p. 186-192 (1989).
J. Melnick, Classification of Hepatitis A Virus as Enterovirus Type 72 and of Hepatitis B Virus as Hepadnavirus Type 1, Intervirology vol. 18: p. 105-106 (1982).
W. Parks et al., Characterization of Marmoset Hepatitis Virus, The Journal of Infectious Diseases vol. 120 No. 5: p. 548-559 (1969).
S. Feinstone et al., Hepatitis A: Detection by Immune Electron Microscopy of a Viruslike Antigen Associated with Acute Illness, Science vol. 182: p. 1026-1028 (1973).
E. Tabor et al., Lack of Susceptibility of Marmosets to Human Non-A, Non-B Hepatitis, The Journal of Infectious Diseases vol. 140 No 5: p. 794-797 (1979).
E. Fagan et al., Toga Virus-Like Particles in Acute Liver Failure Attributed to Sporadic Non-A, Non-B Hepatitis and Recurrence After Liver Transplantation, Journal of Medical Virology vol. 38: p. 71-77 (1992).
J. Dienstag, Virus particles in marmoset hepatitis, Nature vol. 267: p. 729-730 (1977).
F. Deinhardt et al., Hepatitis in Marmosets, The Journal of Infectious Diseases vol. 121 No. 3: p. 351-354 (1970).
F. Deinhardt et al., The Mythology of Various Hepatitis A Virus Isolates, International Symposium on Viral Hepatitis: p. 390-404 (1975).
M. Alter et al., The Natural History of Community-Acquired Hepatitis C in the United States, The New England Journal of Medicine vol. 327 No. 27: p. 1899-1905 (1992).
R. Gibbs, Polymerase chain reaction techniques, Analytical Biotechnology: p. 69-75 (1991).
S. Friedman et al., The core element of the EcoRII methylase as defined by protease digestion and deletion analysis, Nucleic Acids Research vol. 19 No. 19: p. 5403-5408 (1991).
A. Rosenthal et al., Genomic walking and sequencing by oligo-cassette mediated polymerase chain reaction, Nucleic Acids Research vol. 18 No. 10: p. 3095-3096 (1990).
A. Akowitz, Protected endogenous retroviral sequences copurify with infectivity in experimental Creutzfeldt-Jakob disease, Archives of Virology vol. 130: p. 301-316 (1993).
Non-A, Non-B?, The Lancet vol. 2: p. 64-65 (1975).
F. Hollinger, Non-A, Non-B Hepatitis Viruses, Virology : p. 2239-2273 (1990).
J. Dienstag, Non-A, Non-B Hepatitis I. Recognition, Epidemiology, and Clinical Features, Gastroenterology vol. 85 No. 2: p. 439-462 (1983).
J. Strauss et al., Structure and Function of the Flavivirus and Pestivirus Genomes, Viral Hepatitis and Liver Disease: p. 333-344 (1990).
H. Alter et al., Posttransfusion Hepatitis After Exclusion of Commercial and Hepatitis-B Antigen-Positive Donors, Annals of Internal Medicine vol. 77 No. 5: p. 691-699 (1972).
H. Alter et al., Clinical and Serological Analysis of Transfusion-Associated Hepatitis, The Lancet: p. 838-841 (1975).
S. Feinstone et al., Transfusion-Associated Hepatitis Not Due To Viral Hepatitis Type A or B, The New England Journal of Medicine vol. 292 No. 15: p. 767-770 (1975).
J. Simons et al., Identification of two flavivirus-like genomes in the GB Hepatitis agent, Proc. Natl. Acad. Sci. USA vol. 92: p. 3401-3405 (1995).
J. Simons et al. , Isolation of novel virus-like sequences associated with human hepatitis, Nature Medicine vol. 1 No. 6: p. 564-568
Carrick Robert J.
Dawson George J.
Desai Suresh M.
Leary Thomas P.
Muerhoff Anthony Scott
Abbott Laboratories
Becker Cheryl L.
Brumback Brenda G.
Casuto Diannne
Porembski Priscilla
LandOfFree
Hepatitis GB virus recombinant proteins and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis GB virus recombinant proteins and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis GB virus recombinant proteins and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-960143